期刊文献+

紫杉醇联合奈达铂与顺铂联合5氟尿嘧啶/亚叶酸钙治疗晚期食管癌对比研究 被引量:1

Comparative study of clinical effects between paclitaxel plus nedaplatin and cisplatin plus 5-fluorouracil/calcium folinate in advanced esophageal cancer
下载PDF
导出
摘要 目的观察紫杉醇联合奈达铂(TN方案)与顺铂联合5氟尿嘧啶/亚叶酸钙(PLF方案)治疗晚期食管癌的近期疗效和毒副反应。方法将48例晚期食管癌随机分为A、B两组。A组24例应用TN方案,B组24例应用PLF方案,两方案均以21d为1周期。至少化疗两个周期方可评价疗效和毒副反应。结果TN方案有效率54.1%,PLF方案有效率29.2%;两组共同的毒副反应为骨髓抑制,TN组轻度肌肉关节疼痛发生率较高(75%),PLF组消化道毒副反应、肾损害发生率较高。结论TN方案治疗晚期食管癌有效率高于PLF方案,毒副反应可耐受。 Objective rio compare the rrecent effect and side effect of the two regiment between paclitaxel plus nedaplatin(TN) and cisplatin plus 5-fluorouracil / calcium folinate(PLF) in advanced esophageal carcinoma. Methods A total of 48 patients with advanced esophageal cancer were divided into group A and group B randomly. Group A were treated with TN and group B with PLF regiment for 21 days as a cicle. The side ef- feet were evaluated after 2 cicles. Rusults The effective rate in the group A and B was 54.1% and 29.2% respectively. With the common side effect of myelosuppression in two groups. The incidence rates of arthralgia in group A were more higher, and gastrointestinal reaction, renal damage were higher in group B. Conelution TN regiment for advanced esophageal cancer were more effective than PLF regiment and well tolerated.
出处 《海南医学》 CAS 2008年第11期38-39,共2页 Hainan Medical Journal
关键词 紫杉醇 奈达铂 晚期食管癌 Paclitaxel Nedaplatin Advanced esophageal cancer
  • 相关文献

参考文献4

二级参考文献29

  • 1[1]Lebwohl D , Canetta R. Clinical development of platinum complexes in cancer therapy: an historical perspective and an update[J]. Eur J Cancer, 1998,34(10): 1522-1534.
  • 2[2]Muramatsu S, Ku Y, Kuroda Y. Pharmaeokinetic comparison between cisplatin and nedaplatin in hepatic arterial chemotherapy using complete hepatic venous isolation and charcoal hemoperfusion[J]. Jpn J Cancer Chemother,1998,25(9): 1457-1460.
  • 3[3]Kawanishi K, Miyagi Y, Yamamoto J, et al. Cytocidal effect and DNA damage of nedaplatin in vitro by simulating pharmacokinetic parameters[J]. Cancer Chemother Pharmacol,2001,47(4): 303-308.
  • 4[4]Fujii M, Tokumaru Y, Imanishi Y, et al. Combination chemotherapy with nedaplatin and 5-FU for head neck cancer[J]. Jpn J Cancer Chemother, 1998, 25(1):53-58.
  • 5[5]Sasaoka M, Fuua N, Matsumoto A, et al. Alternating chemoradiotherapy for oropharyngeal cancer [J]. Jpm J Cancer Chemother, 2000; 27(14): 2217-2221.
  • 6[6]Takeda Y, Kasai H, Uchida N, et al. Enhanced antitumor efficacy of nedaplatin with 5-fluorouracil against human squamous carcinoma xenografts [J]. Anticancer Res, 1999,19 (5B): 4059-4064.
  • 7[7]Yoshioka T, Gamoh M, Shineha R, et al. A new combimation chemotherapy with cis- diammine- glycolatoplatinum (nedaplatin) and 5-fluorouracil for advanced esoiphageal cancers[J]. Intern Med, 1999, 38(11) :844-848.
  • 8[8]Hirata S, Yatsuyanagi E, Yamazaki H, et al. Neoadjuvant chemotherapy for esophageal cancer by administration of nedaplatin alone[J]. Jpm J Cancer Chemother, 2000, (2):221-226.
  • 9[9]Sumi H, Ohtsu A, Boku N, et al. A case of inoperable esophageal carcinoma with hepatic and nodal metastases which showed a long-term survival after chemradiotherapy including nedaplatin[J]. Jpn J Clin Oncol, 2000, 30(9):406-409.
  • 10[10]Matsumoto M, Takeda Y, Maki H, et al. Preclinical in vivo antitumor efficacy of nedaplatin with gemcitabine against human lung cancer[J]. Jpn J Cancer Res, 2001, 92 (1):51-58.

共引文献72

同被引文献2

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部